In: Comparative Oncology News

  1. Home

Canine Bone Cancer Vaccine Hints at a Human Version

An immunotherapy based on autologous canine osteosarcoma cells resulted in remission for more than 400 days after surgery, compared with 270 days for dogs in a different study treated with chemotherapy, researchers reported at the Veterinary Cancer Society Annual Conference.

ACF Grant 2016 : The Hope of CAR-T Therapy (Update)

Recently, a new treatment for human B cell cancers called CAR-T (Chimeric Antigen Receptor T cell) therapy has made headlines around...

ACF Grant 2018: Canine Osteosarcoma & Tumor Microenvironment

“Cancer cells thrive in many types of microenvironments. Our work seeks to understand some of the genetic expression in these microenvironments,...

ACF Grant 2017: Pioneering Cancer Research

“We are very excited to receive this award to test elephant P53 (EP53) in growing cancer cells that come from pet...

$1M Gift Could Answer The Research Gap

Funds Donated by The Blue Buffalo Foundation Will Help Map the Most Common Canine Cancer Genomes and Place Genomic Data in...

Animal Cancer Foundation Announces $1 Million Gift to Inaugurate Canine Cancer Genome Project

“We are proud to support Animal Cancer Foundation in their important work helping to find ways to cure this terrible disease...

ACF Grant 2016: Canine CAR-T Therapy

“We are absolutely delighted to receive this award from Animal Cancer Foundation to support our ongoing work developing genetically re-directed T-cells...

ACF Grant Awards 2015: Offering Hope to Pets & Pet Parents

“Kids and animals often develop very similar types of cancer. When pediatricians, scientists, and veterinarians work together, research can improve treatments...

Personalized Cancer Treatment Vision

UPDATE (November 2015) –  Institute of Medicine Publishes Workshop Highlights, The Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer...